Literature DB >> 4121785

Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: exacerbations and remissions.

J E Olsson, H Link.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4121785     DOI： 10.1001/archneur.1973.00490240052009

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  30 in total

1.  Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial.

Authors:  R T Naismith; L Piccio; J A Lyons; J Lauber; N T Tutlam; B J Parks; K Trinkaus; S K Song; A H Cross
Journal:  Neurology       Date:  2010-06-08       Impact factor: 9.910

Review 2.  Rituximab in a patient with ankylosing spondylitis with demyelinating disease: a case report and review of the literature.

Authors:  Mohammed A Omair; Khalid A Alnaqbi; Peter Lee
Journal:  Clin Rheumatol       Date:  2012-05-27       Impact factor: 2.980

Review 3.  Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.

Authors:  Anne H Cross; Jennifer L Stark
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

4.  Viral antibodies in cerebrospinal fluid of multiple sclerosis and control patients: comparison between radioimmunoassay and conventional techniques.

Authors:  B Forghani; N E Cremer; K P Johnson; A H Ginsberg; W H Likosky
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

5.  Isoelectric focusing and crossed immunoelectrofocusing of CSF immunoglobulins in MS.

Authors:  A Sidén
Journal:  J Neurol       Date:  1979-07-11       Impact factor: 4.849

6.  Oligoclonal "fingerprint" of CSF IgG in multiple sclerosis patients is not modified following intrathecal administration of natural beta-interferon.

Authors:  C Confavreux; C Chapuis-Cellier; P Arnaud; O Robert; G Aimard; M Devic
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-11       Impact factor: 10.154

7.  Binding of 125I-labelled encephalitogenic basic protein to normal lymphocytes. Inhibition with multiple sclerosis serum.

Authors:  T A McPherson; E M Liburd; T P Seland
Journal:  Clin Exp Immunol       Date:  1975-03       Impact factor: 4.330

8.  B cells as a target of immune modulation.

Authors:  Kathleen Hawker
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

9.  Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries.

Authors:  I Cortese; R Tafi; L M Grimaldi; G Martino; A Nicosia; R Cortese
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

10.  Detection of IgG oligoclonal bands in unconcentrated CSF by means of agarose isoelectric focusing, double immunofixation peroxidase staining and avidin-biotin amplification.

Authors:  P Gallo; F Bracco; L Battistin; B Tavolato
Journal:  Ital J Neurol Sci       Date:  1985-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.